Grayscale Thinks AAVE Path to Higher Prices on Regulation
Grayscale Research outlines a bull case for AAVE, arguing regulatory clarity could push its fair value toward $175 wi...
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articlesGrayscale Research outlines a bull case for AAVE, arguing regulatory clarity could push its fair value toward $175 wi...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
SpaceX could be the market's most talked-about IPO. This guide breaks down what to know, how to evaluate the opportun...
Oklo has faced a challenging six months as the stock trended lower with little revenue to show. This article explores...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
A shift toward a more hawkish Fed path can reshape how we value large banks. This guide breaks down the math, expecta...
As AI startups eye the public markets, anthropic goes public trillion could unlock a new wave of investor opportuniti...
Two cloud stock darlings sit at opposite ends of the growth vs profitability spectrum. This guide breaks down gitlab ...
Two industrial names sit at the center of the rare-earth supply story: MP Materials and TMC The Metals Company. This ...
As the EV market accelerates, some memory-faded battery names may offer outsized upside. This article dives into how ...
Dive into a practical look at how Kleiner Perkins evaluates AI startups, drawn from the transcript: mamoon hamid, kle...